{"id":"W3211808513","doi":"10.1182/blood-2021-154074","title":"Updated Results from a Phase II Study of Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Blinatumomab; Rituximab; Internal medicine; Gastroenterology; Cytarabine; Chemotherapy; Surgery; Leukemia; Lymphoblastic Leukemia; Lymphoma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002679527,0.0009302727,0.002105653,0.0006350344,0.0001969795,0.00006214712,0.0005732634,0.0003961567,0.0002617859],"category_scores_gemma":[0.0006857897,0.0006517692,0.0001232498,0.002891603,0.0004408514,0.0003252756,0.0004683802,0.0008997483,0.00003410368],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001782396,"about_ca_system_score_gemma":0.01057092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004130882,"about_ca_topic_score_gemma":0.004695297,"domain_scores_codex":[0.9933012,0.0003527781,0.001445242,0.00188346,0.001875873,0.001141439],"domain_scores_gemma":[0.9947938,0.001146952,0.0006608967,0.001641009,0.001154079,0.0006032367],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4695473,0.1561135,0.01890689,0.001258916,0.009478743,0.1433126,0.1297821,0.001563617,0.06342817,0.000007866189,0.004682446,0.001917857],"study_design_scores_gemma":[0.7988343,0.03826313,0.01046341,0.003584282,0.003638267,0.001365545,0.02300667,0.01009453,0.1095821,0.000004947174,0.00005614406,0.001106707],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943828,0.0001738548,0.0000726013,0.0003293717,0.00008637344,0.003524326,0.0008874881,0.0001570245,0.0003861759],"genre_scores_gemma":[0.9943309,0.00006968217,0.002731187,0.0002361033,0.0002048079,0.0002958369,0.001082806,0.0002089681,0.0008396886],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.329287,"threshold_uncertainty_score":0.9995934,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01281744692112593,"score_gpt":0.2746609611731929,"score_spread":0.261843514252067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}